树突状细胞神经纤维瘤中的蛋白激酶c - α基因融合:与常规神经纤维瘤的区别。

IF 4.2 1区 医学 Q1 PATHOLOGY
Arnaud de la Fouchardiere, Elizabeth C Draper, Daniel Pissaloux, Marshall Lukacs, Franck Tirode, John Hanna
{"title":"树突状细胞神经纤维瘤中的蛋白激酶c - α基因融合:与常规神经纤维瘤的区别。","authors":"Arnaud de la Fouchardiere, Elizabeth C Draper, Daniel Pissaloux, Marshall Lukacs, Franck Tirode, John Hanna","doi":"10.1097/PAS.0000000000002460","DOIUrl":null,"url":null,"abstract":"<p><p>Dendritic cell neurofibroma with pseudorosettes is an uncommon but distinctive variant of neurofibroma. The pseudorosette structures are formed by the circumferential arrangement of small, dark cells around an eosinophilic core at the center of which there is often a single larger and paler cell with slender dendrite-like projections. Dendritic cell neurofibroma often shows a multinodular architecture, which can cause confusion with plexiform neurofibroma. Since plexiform neurofibroma is essentially pathognomonic of Neurofibromatosis type I, such confusion could lead to unnecessary and costly clinical work-up. Since its description in 2001, there has been controversy as to whether dendritic cell neurofibroma represents a true subtype of neurofibroma, whose defining molecular feature is loss-of-function mutation in NF1. Here we show in a series of 9 cases that dendritic cell neurofibroma harbors recurrent gene fusions involving protein kinase c-alpha (PRKCA), including SLC44A1::PRKCA. Identical gene fusions are known to occur in a rare brain tumor known as papillary glioneuronal tumor, although this entity appears to be morphologically and clinically distinct from dendritic cell neurofibroma. Our results distinguish dendritic cell neurofibroma from conventional types of neurofibroma and raise consideration that dendritic cell neurofibroma may be better classified as a unique type of benign neural tumor.</p>","PeriodicalId":7772,"journal":{"name":"American Journal of Surgical Pathology","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Protein Kinase C-alpha Gene Fusions in Dendritic Cell Neurofibroma: Distinction From Conventional Neurofibroma.\",\"authors\":\"Arnaud de la Fouchardiere, Elizabeth C Draper, Daniel Pissaloux, Marshall Lukacs, Franck Tirode, John Hanna\",\"doi\":\"10.1097/PAS.0000000000002460\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Dendritic cell neurofibroma with pseudorosettes is an uncommon but distinctive variant of neurofibroma. The pseudorosette structures are formed by the circumferential arrangement of small, dark cells around an eosinophilic core at the center of which there is often a single larger and paler cell with slender dendrite-like projections. Dendritic cell neurofibroma often shows a multinodular architecture, which can cause confusion with plexiform neurofibroma. Since plexiform neurofibroma is essentially pathognomonic of Neurofibromatosis type I, such confusion could lead to unnecessary and costly clinical work-up. Since its description in 2001, there has been controversy as to whether dendritic cell neurofibroma represents a true subtype of neurofibroma, whose defining molecular feature is loss-of-function mutation in NF1. Here we show in a series of 9 cases that dendritic cell neurofibroma harbors recurrent gene fusions involving protein kinase c-alpha (PRKCA), including SLC44A1::PRKCA. Identical gene fusions are known to occur in a rare brain tumor known as papillary glioneuronal tumor, although this entity appears to be morphologically and clinically distinct from dendritic cell neurofibroma. Our results distinguish dendritic cell neurofibroma from conventional types of neurofibroma and raise consideration that dendritic cell neurofibroma may be better classified as a unique type of benign neural tumor.</p>\",\"PeriodicalId\":7772,\"journal\":{\"name\":\"American Journal of Surgical Pathology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Surgical Pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/PAS.0000000000002460\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Surgical Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PAS.0000000000002460","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

树突状细胞神经纤维瘤是一种少见但独特的神经纤维瘤。假簇状结构是由嗜酸性核周围的小而暗的细胞呈周向排列形成的,嗜酸性核的中心通常有一个较大的、颜色较浅的细胞,呈细长的树突状突起。树突状细胞神经纤维瘤常表现为多结节结构,可与丛状神经纤维瘤混淆。由于丛状神经纤维瘤本质上是I型神经纤维瘤病的病理特征,这种混淆可能导致不必要的和昂贵的临床检查。树突状细胞神经纤维瘤自2001年被描述以来,一直存在争议,即树突状细胞神经纤维瘤是否代表神经纤维瘤的真正亚型,其定义的分子特征是NF1的功能丧失突变。我们在一系列9例树突状细胞神经纤维瘤中发现复发性基因融合涉及蛋白激酶c- α (PRKCA),包括SLC44A1::PRKCA。相同的基因融合已知发生在一种罕见的脑肿瘤,称为乳头状胶质神经元瘤,尽管这种实体在形态学和临床上与树突状细胞神经纤维瘤不同。我们的结果将树突状细胞神经纤维瘤与传统类型的神经纤维瘤区分开来,并提出树突状细胞神经纤维瘤可能被更好地归类为一种独特的良性神经肿瘤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Protein Kinase C-alpha Gene Fusions in Dendritic Cell Neurofibroma: Distinction From Conventional Neurofibroma.

Dendritic cell neurofibroma with pseudorosettes is an uncommon but distinctive variant of neurofibroma. The pseudorosette structures are formed by the circumferential arrangement of small, dark cells around an eosinophilic core at the center of which there is often a single larger and paler cell with slender dendrite-like projections. Dendritic cell neurofibroma often shows a multinodular architecture, which can cause confusion with plexiform neurofibroma. Since plexiform neurofibroma is essentially pathognomonic of Neurofibromatosis type I, such confusion could lead to unnecessary and costly clinical work-up. Since its description in 2001, there has been controversy as to whether dendritic cell neurofibroma represents a true subtype of neurofibroma, whose defining molecular feature is loss-of-function mutation in NF1. Here we show in a series of 9 cases that dendritic cell neurofibroma harbors recurrent gene fusions involving protein kinase c-alpha (PRKCA), including SLC44A1::PRKCA. Identical gene fusions are known to occur in a rare brain tumor known as papillary glioneuronal tumor, although this entity appears to be morphologically and clinically distinct from dendritic cell neurofibroma. Our results distinguish dendritic cell neurofibroma from conventional types of neurofibroma and raise consideration that dendritic cell neurofibroma may be better classified as a unique type of benign neural tumor.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.30
自引率
5.40%
发文量
295
审稿时长
1 months
期刊介绍: The American Journal of Surgical Pathology has achieved worldwide recognition for its outstanding coverage of the state of the art in human surgical pathology. In each monthly issue, experts present original articles, review articles, detailed case reports, and special features, enhanced by superb illustrations. Coverage encompasses technical methods, diagnostic aids, and frozen-section diagnosis, in addition to detailed pathologic studies of a wide range of disease entities. Official Journal of The Arthur Purdy Stout Society of Surgical Pathologists and The Gastrointestinal Pathology Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信